CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED

Advanced Intermediate for Apremilast 

Color : White / Almost White / Light Yellow / Light Brown Form : Powder L O D (Loss on Drying) : Not more than 1% Sulphated Ash : Not more than 0.5% Foreign Matter : No Foreign Matter Assay by titration: Not less than 99% Packing : HDPE plastic drums with internal PE liners(25 Kg.Net each)

Color : Light Yellow / White or Almost White
Form : Crystals or Crystalline Powder 

Melting Point : Not less than 260-263°C
Color of Solution : Less than GY5
Loss on Drying (%) : Not more than 0.8 


Assay by Titration: 99 - 101%

We are the only suppliers of this product who make it through the hydrogenation route and not the iron acid route, thus completely removing metal impurities, making it ideal for pharmaceutical applications. Physical Appearance Colour : White to Off White Form : Powder. Foreign Matter : No Foreign Ma...

USP Grade Material. 

Color : White / Light Yellow Form : Crystalline Powder Loss on Drying (%) : Not more than 1% Melting Point : Not less than 210C Solubility : Soluble in NaOH 1N Insoluble in ethanol 96% Absorbance of Solution : Not more than 0.040 Total Ash : Not more than 0.1% Assay by titration: Not less than ...

Color : Light Yellow Form : Crystals Melting Point : Not less than 206C Color of Solution : Less than GY5 Absorbance [410 nm] : Less than 0.95 Loss on Drying (%) : Not more than 0.2 Assay : Not less than 99%

Advanced Intermediate for Empagliflozin

Advanced Intermediate for Mirabegron

Ticagrelor Intermediate

Advanced Intermediate for Etoricoxib

Advanced Intermdiate for Rivaroxaban

Chemco is expanding its pharmaceutical manufacturing capabilities through an upcoming GMP unit dedicated to advanced and penultimate intermediates. The facility is being developed to support customer programs linked to APIs including Acalabrutinib, Ambrisentan, Apixaban, Apremilast, Canagliflozin, Chlorthalidone, Dapagliflozin, Sotagliflozin, Doxofylline, Empagliflozin, Etoricoxib, Famotidine, Ibrutinib, Mirabegron, Tazemetostat, Ticagrelor and Praziquantel.

The new unit will support process development, technology transfer, scale-up and commercial manufacturing, with a focus on reliable execution, long-term supply and customer-specific intermediate programs.

We are thrilled to share our Keynote 2025/26 address by Mr. Samir Mody, Director of Chemco Group. He highlights our journey of innovation, recent advancements i

Established in 1976, Chemco is an Indian manufacturer with deep expertise in nitration and specialty chemistry. We are now advancing into KSMs, advanced and penultimate pharmaceutical intermediates, supporting customers from development and technology transfer through scale-up and long-term commercial manufacturing.

Upcoming GMP Unit - December 2026. 

Please find our product list here.